the First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
NCT Number: NCT04660474
The aim of this study was to investigate the association between different reperfusion timing and ventricular arrhythmias (VAs) to provide evidence for clinical decision-making for patients with ST-segment elevation myocardial infarction (STEMI). All the participants included in the study were diagnosed with STEMI according to the 4th universal definition of myocardial infarction, with a follow-up of 1, 6, 12 months, respectively. Symptom onset-to-reperfusion timing (SO2RT) and 24h-dynamic electrocardiogram parameters were recorded to compare different SO2RT and VAs during 3 follow-up visits.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Nanjing, Jiangsu, China
It is Class I recommendation that STEMI require emergency revascularization with no delay. However, arrhythmias after acute myocardial infarction (AMI), particularly VAs, also occur in the early post-MI phase, leading to increased mortality. Previous studies have shown benefits of late reperfusion to electrical stability. The aim of this study was to investigate the association between different reperfusion timing and VAs to provide evidence for clinical decision-making for STEMI. In this multicenter, prospective, observational study, STEMI participants from July 2019 to December 2020 confirmed according to the 4th universal definition of myocardial infarction were enrolled, with a follow-up of 1, 6, 12 months, respectively. SO2RT was defined as the time interval between symptom onset and reperfusion timing which referred to the timing when coronary angiography showed Thrombolysis In Myocardial Infarction (TIMI) blood flow level 2~3 immediately after percutaneous coronary intervention (PCI). The primary end point was VAs on 24h-dynamic electrocardiogram. Secondary outcomes included a composite of death from coronary heart disease, fetal of non-fetal ischemic stroke, revascularization, or chest pain requiring readmission.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
The incidence of ventricular arrhythmias on 24h-dynamic electrocardiogram.
Time frame: 12 months
The incidence of death from coronary heart disease during follow-ups.
Time frame: 12 months
The incidence of fetal of non-fetal ischemic stroke during follow-ups.
Time frame: 12 months
The incidence of revascularization during follow-ups.
Time frame: 12 months
The incidence of chest pain requiring readmission during follow-ups.
The First Affiliated Hospital with Nanjing Medical University
Other
Association of Reperfusion Timing With Short- and Medium-term Ventricular Arrhythmias in Patients With ST-segment Elevation Myocardial Infarction: A Prospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05605288
Arterial Occlusive Diseases, Arteriosclerosis
Charleroi, Belgium
View Trial DetailsNCT04573751
Cardiovascular Diseases, Heart Diseases
Tomsk, Tomsk Oblast, Russia
View Trial DetailsNCT05462730
Cardiomyopathies, Cardiovascular Diseases
Copenhagen, Capital Region, Denmark
View Trial DetailsNCT05848674
Cardiovascular Diseases, Heart Diseases
Belfast, Antrim, United Kingdom
View Trial Details